Agranulocytosis Associated with Maloprim: Review of Cases
- 1 July 1986
- journal article
- review article
- Published by SAGE Publications in Human Toxicology
- Vol. 5 (4) , 221-227
- https://doi.org/10.1177/096032718600500402
Abstract
1 Twenty-one cases of agranulocytosis following dosage with one tablet of Maloprim given once or twice weekly are reviewed.2 Of the 18 individuals for whom the dose is certain 12 were taking twice-weekly Maloprim. Time of onset was 7-9 weeks in 15 of 19 cases where duration of dosage is known.3 Nine patients died, 12 recovered. Of those who died six were taking Maloprim twice weekly, one once weekly and two at an uncertain dosage.4 The available data suggest that this is an idiosyncratic reaction to dapsone exacerbated by the concomitant administration of pyrimethamine.This publication has 35 references indexed in Scilit:
- Dapsone acetylation in dermatitis herpetiformisBritish Journal of Dermatology, 2006
- Agranulocytosis during malaria prophylaxis with Maloprim (pyrimethamine and dapsone)Published by Oxford University Press (OUP) ,1984
- Agranulocytosis associated with malaria prophylaxis with Maloprim.BMJ, 1983
- Pharmacokinetic observations on dapsone in dermatitis herpetiformisBritish Journal of Dermatology, 1983
- In Vitro Inhibition of Granulopoiesis by 4‐Amino‐4′‐Hydroxylaminodiphenyl SulfoneBritish Journal of Haematology, 1980
- Improvement of Polymorphonuclear Leucocyte Oxidative and Bactericidal Functions in Chronic Granulomatous Disease with4-Amino-4'-4 Hyndroxylaminodiphenyl SulphoneBritish Journal of Haematology, 1978
- Mechanisms of Microtubule Disassembly in Vivo: Studies in Normal and Chronic Granulomatous Disease LeucocytesBritish Journal of Haematology, 1977
- ADVERSE EFFECTS OF DAPSONEInternational Journal of Dermatology, 1975
- Agranulocytosis during Dapsone AdministrationDermatology, 1973
- ABSORPTION AND EXCRETION OF 35S DAPSONE IN DERMATITIS HERPETIFORMISBritish Journal of Dermatology, 1970